The Role of Gender in the Importance of Risk Factors for Coronary Artery Disease by Gheisari, Farshid et al.
Research Article
The Role of Gender in the Importance of Risk Factors for
Coronary Artery Disease
Farshid Gheisari,1 Melika Emami ,1 Hadi Raeisi Shahraki,2 Saeid Samipour,3
and Parastoo Nematollahi4
1Ionizing and Non-Ionizing Radiation Protection Research Center, School of Paramedical Sciences,
Shiraz University of Medical Sciences, Shiraz, Iran
2Department of Epidemiology and Biostatistics, Faculty of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran
3Department of Chemical Engineering, School of Chemical and Petroleum Engineering, Shiraz University, Shiraz, Iran
4School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Correspondence should be addressed to Melika Emami; melikaemami20@gmail.com
Received 1 August 2019; Revised 3 December 2019; Accepted 14 July 2020; Published 29 July 2020
Academic Editor: Robert Chen
Copyright © 2020 Farshid Gheisari et al. )is is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Identification of risk factors and their importance in different genders is essential in order to prevent, diagnose, and manage
coronary artery disease (CAD) properly. )e present study aims to investigate the role of gender in the distribution of different
risk factors in ischemic heart disease.)is study is a cross-sectional study. More than one thousand (N� 1012) patients referring to
the Nuclear Medicine Department in Namazi Hospital, Shiraz, Iran, from March 2017 to March 2018 were studied. )e patients’
demographic data and their clinical history were collected. )e results of the myocardial perfusion scan were recorded and
compared between groups. Statistical analysis was implemented by SPSS version 18.0, and P values below 0.05 were considered
statistically significant. Out of the 1012 patients participating in this study, 698 (69%) were female and 314 (31%) were male.
Ischemic heart disease (IHD) was significantly higher in men compared to women (19.1% versus 14.2%). )e higher levels of
systolic and diastolic blood pressures, along with older age, were a significant risk factor in women (P< 0.05). Previousmyocardial
infarction (MI), diabetes mellitus (DM), hypertension (HTN), and hyperlipidemia (HLP) had a strong correlation with IHD in
our female population. Regarding the male subjects, previousMI and HLP had a lower correlation with IHD. Based on our logistic
regression models, investigation of the simultaneous effects of risk factors on IHD showed that previous MI is the most effective
risk factor in females (OR� 3.93) mostly in terms of residual ischemia in the infarctedmyocardium. In themale population, on the
other hand, HTN was identified as the most effective risk factor for IHD (OR� 2). In conclusion, we found that older age, higher
blood pressure, DM, previous MI, HTN, and HLP have a significant association with IHD in the female population, whereas older
age, DM, and HTNwere significant risk factors for IHD inmales. Also, the most effective factor for women was previousMI, while
it was HTN for the male population.
1. Introduction
Atherosclerosis is characterized as an abnormal progressive
remodeling process of the arterial wall in which various
specified organs are endangered by ischemia, leading to
coronary artery disease (CAD) and other related cardio-
vascular disorders [1–4]. Deaths from cardiovascular dis-
eases are the most frequent cause of death globally, and the
number of these deaths is expected to grow to 23.6 million
in the following 20 years [2, 5, 6]. However, there are
significant pharmacological and treatment protocol de-
velopments recently targeted at CVD patients, which im-
proves their prognosis and could decrease the mortality
rate [7].
Atherosclerosis pathophysiology could vary between
genders [4, 8]. Additionally, coronary artery disease (CAD)
is often underdiagnosed and viewed as a leading cause of
female mortality. However, European data show that the
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degree of reduction in age-adjusted mortality for CVDs is
more moderate for women than for men [9].
Several risk factors have been introduced for CAD,
which are associated with acute MI in both women and men
[10]. )ese include modifiable risk factors such as abnormal
lipid levels, smoking, hypertension, abdominal obesity, lousy
diet habit, mental stress, and diabetes [10]. )ere are also
nonmodifiable risk factors, including male gender, age, and
family history [10]. Because the initiation of clinical
symptoms of CAD occurs later in women (about ten years
later in women versus men), women diagnosed with CAD
are often older with a likely higher prevalence of presented
cardiovascular risk factors [2, 11].
)ough traditional risk factors for CVD are expressed
almost equally in both genders, determining the importance
and relative weighting of these factors in each gender are not
the same [4, 8].
According to a well-respected report, women and men
had similar odds with respect to the relationship between
acute myocardial infarction (AMI), smoking, elevated lipid
levels, abdominal obesity, psychosocial influences, and
vegetable and fruit intake [12]. Nonetheless, when it comes
to the risk of hypertension and diabetes, as well as the
protective effects of exercise and alcohol, the findings are
more pronounced for women than for men [13–15]. Ad-
ditionally, older women were reported to be more prone to
hypertension than older men, which is strongly associated
with stroke, left ventricular hypertrophy, and diastolic
heart failure [13]. )e cardiovascular problems associated
with type 2 diabetes are more severe in women than in men,
according to a meta-analysis of 37 prospective cohort
studies [14]. Younger women suffer less from hypercho-
lesterolemia compared to men, and although as they reach
65 and above, the mean LDL-cholesterol levels will increase
in them [2, 15].
Different changes occurring during pregnancy and
physiological differences in hormonal levels during meno-
pause may explain this difference between men and women.
Besides, women with hypercholesterolemia, reduced insulin
sensitivity, volume excess during pregnancy, and also pos-
sible complications such as pre-eclampsia, gestational dia-
betes, and pregnancy-related hypertension are more prone
to a higher risk of CVD later down the line [16]. Lastly,
substantial changes in hormone levels during menopause
processes (i.e., decreased levels of estrogen) may result in
harmful alterations in cardiovascular risk factors [17].
Nonetheless, circulating estrogens control many metabolic
pathways such as lipids, inflammatory markers, and the
coagulation system [2, 18].
Identifying these risk factors and their gender-related
disparities are, therefore, crucial for the proper prevention,
treatment, and management of CAD. )ere are different
diagnostic methods for diagnosing cardiovascular diseases
such as electrocardiography, cardiac stress tests, myocardial
perfusion scans, coronary computed tomography, and
coronary angiography [19, 20]. As a more sensitive method
for detecting myocardial ischemia, stress-rest myocardial
perfusion imaging (MPI) was implemented in the mid-to-
late 1970s [21]. )e test was claimed to provide additional
diagnostic and prognostic knowledge as opposed to ECG
exercise and has since been significantly favored [22].
)e radionuclide stress testing was considered a foun-
dation for the practice and treatment of patients with sus-
pected and confirmed coronary artery disease in the coming
decades [23]. Given the global prevalence of CAD and its
high mortality rate, it is essential to understand the sig-
nificant risk factors for cardiovascular disease and to prevent
and monitor these risk factors to reduce their adverse effects
[8, 12, 16]. )e appearance of one or more risk factors in an
individual does not necessarily imply that heart disease is
present, nor does it contribute to the absence of cardio-
vascular disease to regulate them [24]. Managing main risk
factors can, moreover, help to reduce the risk of CAD and
monitor the rate of disease progression or consequences and
its complications [16, 20]. Considering the importance of
CAD mortality and morbidity in both genders and the
underestimation of heart disease risk in women and due to
the lack of comprehensive information on risk factor dif-
ferences in male and female, the present study aims to in-
vestigate the role of gender in each risk factor in
cardiovascular disease.
2. Materials and Methods
)is study is a cross-sectional study conducted in Namazi
Hospital affiliated to the Shiraz University of Medical Sci-
ences. More than one thousand (N� 1012) patients referring
to the Nuclear Medicine Department in Namazi Hospital
fromMarch 2017 to March 2018 were studied. )e inclusion
criteria were patients needing IHD assessment and MPI and
those aged older than 30 from both genders. )e exclusion
criteria were patients who had contraindications for un-
dergoing stress-MPI based on clinical guidelines and had
poor quality imaging, as well as patients unwilling to par-
ticipate in the study. )e patients’ demographic data and
their clinical history were collected by in-person interviews
or reviewing their medical records. )e data collection form
included age, sex, weight, height, body mass index, labo-
ratory results such as total cholesterol, triglyceride, FBS,
LDL, and HDL, positive history of chronic disease (diabetes,
hypertension, and hyperlipidemia), smoking, family history
of ischemic heart disease (first-degree relative), past history
of CCU admission, previous history of coronary angiog-
raphy, prior myocardial infarction, and coronary artery
bypass graft or percutaneous transluminal angioplasty. )e
results of the MPI test were recorded and compared between
groups.
)is study was found to be in accordance with the ethical
principles and the national norms and standards for con-
ductingmedical research in Iran.)e proposal was approved
by the Research Ethics Committee of the Shiraz University of
Medical Sciences (approval date: 2019-02-12; approval ID :
IR.SUMS.MED.REC.1397.517).
2.1. Statistical Analysis. Statistical analysis was implemented
by SPSS version 18.0, and P values less than 0.05 were
considered statistically significant.)e trend test was used to
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examine trends between the nominal and ordinal variables.
In addition, the chi-square test and the independent t test
were used where appropriate for assessing the association
between the understudy factors and the status of IHD. To
determine the simultaneous effect of potential risk factors on
IHD, all variables with a P value 0.2 or less in univariate
analysis were considered in multiple logistic regression
(conditional backward elimination with alpha-to-
remove� 0.1).
3. Results
Out of the 1012 patients participating in this study, 698
(69%) were female and 314 (31%) were male. )e mean age
of males and females was 57.4 (13.1) and 56.4 (12.0), re-
spectively, which was not significantly different (P � 0.23).
)e male and female participants of this study had also
similar values in terms of mean blood pressure (93.3 versus
94.7, P � 0.32), but the proportion of IHD among males was
significantly higher than females (19.1% versus 14.2%,
P � 0.046).
)e trend test showed a significant association between
the proportion of IHD in females and a higher level of
systolic or diastolic blood pressure (P � 0.001 for systolic
and P � 0.009 for diastolic). Besides, female patients with
IHD had a significantly higher blood pressure and were
older compared to other females (P< 0.001 and P � 0.002,
respectively). On the other hand, there was no correlation
between the proportion of IHD and the level of systolic and
diastolic blood pressure in males (P � 0.18 and 0.81, re-
spectively). Also, males with IHD were significantly older
than the other males (P � 0.003), but they had similar values
in terms of weight and blood pressure (Table 1).
As far as disease comorbidity was concerned, the pro-
portion of IHD in females with previousMI was significantly
higher than that in females without previous MI (44% versus
13.1%, P< 0.001), but there was no association between IHD
and previous MI in males P � 0.61. )e chi-square test
revealed that there was a significant association between
IHD and DM in both genders (P � 0.008 and 0.037 for
females and males, respectively) as odds of IHD for DM
patients were higher. HTN was another disease leading to
increased odds of IHD in males and females (Table 2).
Although the proportion of IHD in male patients with
and without HLP was the same, the proportion of IHD in
female patients with HLP was significantly higher than that
in females without HLP (17.2% versus 11.6%, P � 0.03).
Moreover, there was no association between smoking,
opium addiction, and obesity with IHD in both males and
females (Table 2).
In order to investigate the simultaneous effects of factors
on the risk of IHD, two separate logistic regression models
were fitted for males and females. We determined the final
model using backward elimination with alpha-to-remove
equal to 0.1.
)e fitted model introduced previous MI as the most
effective risk factor in females as odds of IHD in females with
previous MI disease was 3.93 times more than that in other
females. Ourmodel also indicated that an eight-year increase
in females’ age would result in a 1.5-fold increase in their
odds of having IHD (Table 3).
)e regression model for males represented HTN as the
most effective factor in IHD. Odds of IHD for males with
HTN were about two times more than those for the other
males (P � 0.03). Moreover, increasing each 20 year in
males’ age would lead to a 1.5-fold increase in their odds of
having IHD (Table 3).
4. Discussion
)e role of the major cardiovascular risk factors in the de-
velopment of IHD had unremarkable similarity in genders
[8, 9]. As known, the overall risk factor level was more fa-
vorable in young females thanmales. However, the advantages
of the female gendermarkedly diminished as they get older [4].
Consistent with our results, the statistical analysis showed that
older age is a common risk factor in both genders.
Based on our study, IHD is more common inmen (19.1%
versus 14.2%). Moreover, in Wegner’s study [25], the results
showed that CAD and the first acute myocardial infarction
occur several years later in women compared to men.
Women’s well-known biological defense against CAD before
menopause can cause more than ten years of delay in
presenting CAD symptoms in their bodies. Men under 55
are nearly four times more likely to developMI than women.
However, when they get older, the gender gap is decreased,
but the prevalence of MI is still lower in women during their
life as CHD levels do not increase suddenly in women at
menopause. Finally, Wegner reported that overall 49% of
men compared to 32% of women over 40 years of age are at a
risk of CHD [25].
Likewise, Abbasi et al. [26] studied gender differences in
terms of the risk of coronary artery disease (CAD) in Iran.
)ey reported that of the 44,820 patients they studied, 37,358
had angiographically documented CAD. According to their
study, CAD was more common in men (25,363) than
women (11,995). )ey also found that the women were
older, less educated, and more overweight than males [26].
In our study population, a higher level of systolic and
diastolic blood pressure, along with older age, was a sig-
nificant risk factor in women. We did not find a consistent
trend between the level of blood pressure in males and the
proportion of IHD; however, the logistic regression models
showed that HTN was the most effective factor in IHD
(OR� 3.54).
Wei et al. [27] performed a systematic review and meta-
analysis to shed more light on sex-related variations re-
garding the impact of systolic blood pressure (SBP) on the
risk of cardiovascular disease (CVD) and mortality. )ey
estimated that the pooled effect size for increased risk of
CVD per 10mm Hg increase in SBP was 25 percent for
women and 15 percent for men. For both women and men,
the average increase in CVD mortality per 10mm Hg SBP
increase was the same. )e results revealed that the risk of
CVD per 10mm Hg SBP rise for women was 1.1-fold higher
than that for men, allowing some changes to age and baseline
SBP. Nonetheless, the gender differences between men and
women in CVD mortality were not relevant [27].
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Studying the impact of disease comorbidity and ischemic
heart disease revealed that previous MI, DM, HTN, and HLP
have a strong correlation with IHD in our female population.
However, in male subjects, previous MI and HLP had a
lower association with IHD in our study population. In fact,
residual ischemia in the infarcted myocardium is more
common in women than men.
Madonna et al. [28] reviewed the impact of sex differ-
ences and diabetes on CAD and IHD.)ey reported that the
cardiovascular risk in people with diabetes is two to three
times higher than those without the disease, and it is believed
that there is a difference in the risk of these diseases in
women and men [28].
Eastwood and Doering also emphasized the fact that
conventional risk factors differ among men and women [29].
Previously, it was believed that the gender difference was
related to estrogen in the premenopausal period. However,
they found that the most significant difference is diabetes
mellitus, which leads to a notably higher increase in CAD risk
in women compared to men, and the reason for this disparity
Table 2: Disease comorbidity and conditions in the study populations and their role in IHD.
Comorbidity disease Female Male
With IHD Without IHD With IHD Without IHD
Previous MI [N (%)] No 88 (13.1) 585 (86.9) 52 (18.7) 226 (81.3)Yes 11 (44.0) 14 (56.0) 8 (22.2) 28 (77.8)
Chi-square test P value <0.001 0.61
DM [N (%)] No 57 (11.8) 425 (88.2) 41 (17.9) 188 (82.1)Yes 42 (19.4) 174 (80.6) 19 (22.4) 66 (77.6)
Chi-square test P value 0.008 0.037
HLP [N (%)] No 44 (11.6) 335 (88.4) 41 (19.0) 175 (81.0)Yes 55 (17.2) 264 (82.8) 19 (19.4) 79 (80.6)
Chi-square test P value 0.03 0.93
HTN [N (%)] No 25 (8.3) 276 (91.7) 22 (13.3) 143 (86.7)Yes 74 (18.6) 323 (81.4) 38 (25.5) 111 (74.5)
Chi-square test P value <0.001 0.006
Smoking [N (%)] No 79 (14.3) 473 (85.7) 34 (19.1) 144 (80.9)Yes 20 (13.7) 126 (86.3) 26 (19.1) 110 (80.9)
Chi-square test P value 0.85 0.99
Opium [N (%)] No 84 (15.1) 473 (84.9) 37 (20.1) 147 (79.9)Yes 15 (10.6) 126 (89.4) 23 (17.7) 107 (82.3)
Chi-square test P value 0.18 0.59
Obesity [N (%)] No 59 (13.8) 368 (86.2) 50 (19.8) 203 (80.2)Yes 40 (14.8) 231 (85.2) 10 (16.4) 51 (83.6)
Chi-square test P value 0.73 0.55
All the information is presented as frequency (%).
Table 1: Risk factors for men and women and comparison of their association with IHD.
Female Male
With IHD Without IHD With IHD Without IHD
Systolic [N (%)]
Normal 22 (9.6) 207 (90.4) 14 (12.5) 98 (87.5)
Pre 33 (13.9) 205 (86.1) 30 (26.5) 83 (73.5)
H1 30 (17.8) 139 (82.2) 8 (14.0) 49 (0.86)
H2 11 (20.0) 44 (80.0) 6 (22.2) 21 (77.8)
H3 3 (42.9) 4 (57.1) 2 (40.0) 3 (60.0)
Trend test P value 0.001 0.19
Diastolic [N (%)]
Normal 55 (11.7) 414 (88.3) 38 (17.9) 174 (82.1)
Pre 8 (21.1) 30 (78.9) 9 (36.0) 16 (64.0)
H1 25 (17.4) 119 (82.6) 12 (19.7) 49 (80.3)
H2 11 (23.9) 35 (76.1) 1 (7.1) 13 (92.9)
H3 0 (0) 1 (100) 0 (0) 2 (100)
Trend test P value 0.009 0.81
Age [mean (STD)] 63.0 (10.7) 55.3 (11.9) 61.3 (10.1) 56.5 (13.6)
t-test P value <0.001 0.003
Weight [mean (STD)] 69.3 (13.8) 68.3 (12.7) 74.1 (11.4) 73.4 (12.8)
t-test P value 0.48 0.70
Blood pressure [mean (STD)] 104.1 (46.4) 93.1 (14.4) 96.0 (15.2) 92.7 (15.6)
t-test P value 0.02 0.14
All the information is presented as frequency (%).
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in gender is unknown. Dyslipidemic women aged over 65
years are at a higher risk of CHD than men. Eastwood and
Doering emphasized the effect of high triglyceride level and
low levels of HDL on CAD risk in women [29]. Also, in their
literature review, Oikonomu et al. [30] dealt with the gender
difference in diabetes mellitus and CHD risk.)ey found that
the mechanisms of insulin resistance and diabetes mellitus
and CHD risk factor profiles are different in women. Still, the
life-long variation of sex hormone levels in women compli-
cates the research and understanding of this issue [30].
In conclusion, further studies are needed to illustrate the
gender-specific hormone variation, risk factor profile, and
gender difference in management outcomes based on dia-
betes mellitus and CVD interaction.
Previously, we studied the impact of smoking and opium
abuse on IHD risk and found that there was no association
between smoking, opium addiction, and obesity with IHD in
both males and females.
Nonetheless, Abbasi et al. [26] reported that all the tra-
ditional risk factors were significantly dissimilar between both
genders. Contrary to our findings, cigarette smoking was the
most common risk factor inmen (54%), whereas hypertension
had the highest frequency (73%) in women with CAD.
Comparing the risk factors between both genders showed that
the frequency of male cigarette smokers or opium users was
significantly higher than females; however, women had a
higher frequency of a positive history for hypertension, dia-
betes mellitus, family history of CAD, hypertriglyceridemia, or
hypercholesterolemia in their study population [26].
Based on our logistic regression models, investigation of
the simultaneous effects of risk factors on IHD showed that
previous MI is the most effective risk factor in females
(OR� 3.93) mostly in terms of residual ischemia in infarcted
areas. In the male population, HTN was realized as the most
effective risk factor for IHD (OR� 2).
Our model also indicated that an eight-year increase in
females’ age would result in a 1.5-fold increase in their odds
of having IHD and a 20-year increase in males had the same
effect on IHD.
According to Blum and Blum [31], the prevalence of
CAD was significantly lower in women <60 years than in
older females. In women aged more than 60, the CAD rate
elevated and exceeded the level of CAD risk reported inmen.
)e atherosclerosis process in coronary arteries is different
based on gender, and the difference would become larger at
older ages (55< years) [31].
Eastwood andDoering identified a high prevalence of CAD
risk factors in US women aged between 20 and 70s. Hyper-
tension, increased cholesterol level, smoking, overweight, and
low physical activity were the most reported risk factors in the
female population [29]. Conventionally, coronary heart disease
(CHD) has been considered as a disease affecting mainly men,
and for a long time, womenwere not studied for cardiovascular
research purposes [32]. However, several recent studies
highlighted the existence of a gender difference in terms of risk
factors, symptoms, presentations, and applying the diagnostic
and therapeutic procedures in women with IHD [8, 26, 29, 33].
Most risk factors contribute to IHD in both men and women,
but the individual risk factors might exert their effects dif-
ferently [8, 26, 29].
5. Conclusion
In conclusion, we found that older age, higher blood
pressure, DM, previous MI, HTN, and HLP have a signif-
icant association with IHD in the female population;
however, older age, DM, and HTN were significant risk
factors for IHD in males. )e most effective factor for
women was previous MI; on the other hand, HTN was the
most influential risk factor in the male population.
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Table 3: Results of separate regression models for women and men.
Female Male
OR (95% CI) P value OR (95% CI) P value
Age 1.05 (1.03,1.07) <0.001 1.02 (1.0,1.05) 0.04
HTN status (yes vs no) — — 1.96 (1.08,3.54) 0.03
Blood pressure 1.02 (1.0,1.04) 0.005 — —
Previous MI (yes vs no) 3.93 (1.59,9.73) 0.003 — —
Opium consumption status (yes vs no) 0.56 (0.3,1.06) 0.07 — —
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